GB8608310D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8608310D0
GB8608310D0 GB868608310A GB8608310A GB8608310D0 GB 8608310 D0 GB8608310 D0 GB 8608310D0 GB 868608310 A GB868608310 A GB 868608310A GB 8608310 A GB8608310 A GB 8608310A GB 8608310 D0 GB8608310 D0 GB 8608310D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB868608310A
Other versions
GB2173699A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of GB8608310D0 publication Critical patent/GB8608310D0/en
Publication of GB2173699A publication Critical patent/GB2173699A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GB08608310A 1985-04-05 1986-04-04 Pharmaceutical compositions with antilactational activity Withdrawn GB2173699A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8520273A IT1215261B (en) 1985-04-05 1985-04-05 PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.

Publications (2)

Publication Number Publication Date
GB8608310D0 true GB8608310D0 (en) 1986-05-08
GB2173699A GB2173699A (en) 1986-10-22

Family

ID=11165332

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08608310A Withdrawn GB2173699A (en) 1985-04-05 1986-04-04 Pharmaceutical compositions with antilactational activity

Country Status (5)

Country Link
JP (1) JPS61280430A (en)
DE (1) DE3525388A1 (en)
FR (1) FR2579894A1 (en)
GB (1) GB2173699A (en)
IT (1) IT1215261B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
DE102007014947B4 (en) * 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilized aqueous solutions of ergoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2311071A1 (en) * 1973-03-06 1974-09-12 Sandoz Ag Use of prolactin inhibitors - for treatment of nephropathies and chronic nephritis
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
PH15001A (en) * 1977-07-25 1982-03-22 Sandoz Ag Prolactin secretion inhibitors

Also Published As

Publication number Publication date
IT8520273A0 (en) 1985-04-05
JPS61280430A (en) 1986-12-11
IT1215261B (en) 1990-01-31
DE3525388C2 (en) 1988-04-14
GB2173699A (en) 1986-10-22
FR2579894A1 (en) 1986-10-10
DE3525388A1 (en) 1986-10-09

Similar Documents

Publication Publication Date Title
GB8626808D0 (en) Pharmaceutical compositions
GB8524001D0 (en) Pharmaceutical composition
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8602787D0 (en) Pharmaceutical composition
GB8602788D0 (en) Pharmaceutical composition
GB8621577D0 (en) Pharmaceutical compositions
GB8530796D0 (en) Pharmaceutical composition
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
GB8508508D0 (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
GB8607848D0 (en) Pharmaceutical compositions
GB8618590D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8618589D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)